Crohn's Disease and Colitis Trial, Recruiting NCT03681652 Sponsor: Schneider Children's Medical Center, Israel Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT03681652
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease
  • You are between 6 and 17 years old (inclusive)
  • Your Crohn's disease affects specific parts of the bowel — either the small intestine only, or both the small intestine and large intestine (confirm with trial site regarding "L1 or L3 phenotypes")
  • You have had surgery to remove part of your bowel (the area where the small and large intestines meet) within the last 3 months
  • You do not currently have any active disease around the anal area, such as draining fistulas or abscesses near the anus
  • You have already started taking medication to help prevent the Crohn's disease from coming back, either a thiopurine or an anti-TNF medication (confirm with trial site if unsure which type you are taking)

Who may not be able to join:

  • You are currently pregnant
  • You have kidney failure
  • You currently have an abscess or a hole (perforation) in your bowel
  • You have developed a complication inside your abdomen after your surgery, such as an abscess or abnormal connection between organs (fistula)
  • You have a heavily draining fistula near the anal area (a mild or non-draining fistula may still be acceptable — confirm with trial site)
  • You have previously had cancer
  • You currently have a serious blood infection (sepsis) or an active bacterial infection
  • Your inflammatory bowel disease has not been clearly classified as Crohn's disease specifically

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amit Assa, MD, Schneider Children's Medical Center, Israel

Phone: +972543522211

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Schneider Children's Medical Center, Israel
Registry
ClinicalTrials.gov
Start date
11 February 2019
Est. completion
31 December 2026

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Endoscopic recurrence (Rutgeerts score ≥ i2b)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov